Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satavaptan in SIADH
NCT00032734Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2001
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in syndrome of inappropriate antidiuretic hormone secretion (SIADH) and hyponatremia comparing Satavaptan with Placebo (2 arms). Primary endpoint: Serum sodium concentration. Started Jun 2001; status: completed.
02
Drugs
satavaptan
03
Conditions
syndrome of inappropriate antidiuretic hormone secretion (SIADH)hyponatremia
Beyond the preview
Go deeper on NCT00032734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032734.